ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 14 filers reported holding ACASTI PHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $17 | -5.6% | 30 | 0.0% | 0.00% | – |
| Q1 2021 | $18 | +80.0% | 30 | 0.0% | 0.00% | – |
| Q4 2020 | $10 | +66.7% | 30 | 0.0% | 0.00% | – |
| Q3 2020 | $6 | -57.1% | 30 | 0.0% | 0.00% | – |
| Q2 2020 | $14 | +27.3% | 30 | 0.0% | 0.00% | – |
| Q1 2020 | $11 | -85.1% | 30 | 0.0% | 0.00% | – |
| Q4 2019 | $74 | +29.8% | 30 | 0.0% | 0.00% | – |
| Q3 2019 | $57 | +67.6% | 30 | 0.0% | 0.00% | – |
| Q2 2019 | $34 | +9.7% | 30 | 0.0% | 0.00% | – |
| Q1 2019 | $31 | +24.0% | 30 | 0.0% | 0.00% | – |
| Q4 2018 | $25 | -35.9% | 30 | 0.0% | 0.00% | – |
| Q3 2018 | $39 | +129.4% | 30 | 0.0% | 0.00% | – |
| Q2 2018 | $17 | -45.2% | 30 | 0.0% | 0.00% | – |
| Q1 2018 | $31 | +10.7% | 30 | 0.0% | 0.00% | – |
| Q4 2017 | $28 | -34.9% | 30 | 0.0% | 0.00% | – |
| Q3 2017 | $43 | – | 30 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTACT INVESTMENT MANAGEMENT INC. | 48,990 | $81,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 40,000 | $52,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 154,427 | $199,000 | 0.00% |
| BREWIN DOLPHIN LTD | 30 | $39 | 0.00% |
| Renaissance Technologies | 61,195 | $79,000 | 0.00% |
| ROYAL BANK OF CANADA | 4,075 | $5,000 | 0.00% |